Search Results 181-190 of 843 for 자격증위조
To evaluate the efficacy of Cinryze® given for the treatment of acute antibody-mediated rejection (of renal allograft) (AMR) in kidney transplant recipients as ...
This study attempts to shift when the nurse anesthesia community introduces substance abuse education by providing such education to registered nurses prior to ...
About this study. This phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not ...
SUMMARY. Dr. Szurszewski studies molecular, cellular and physiological processes that control gastrointestinal motility. His current research interests are ...
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; ...
The purpose of this study is to assess the safety, tolerability, and best study dose of BBI608 when administered in combination with Gemcitabine and nab- ...
intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...
... . VID-20321385. Home; Honoring Our Founders: The Mayo Ancestors Statue in Arizona. Have 2X the impact! Give Today. Make a gift that can go twice as far ...
Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin and ...
The purpose of this research is to see how well fruquintinib works in combination with tislelizumab in participants with metastatic colorectal cancer (mCRC).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.